Jennison Associates
NARI icon

Jennison Associates’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Jennison Associates’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,763,258
Closed -$90M – 645
2024
Q4 		$90M Buy
1,763,258
+186,617
+12% +$9.17M 0.05% 148
2024
Q3 		$65M Buy
1,576,641
+610,468
+63% +$29.3M 0.04% 183
2024
Q2 		$46.5M Buy
966,173
+622,734
+181% +$27.6M 0.03% 220
2024
Q1 		$16.5M Sell
343,439
-100,070
-23% -$5.35M 0.01% 358
2023
Q4 		$28.8M Buy
443,509
+33,419
+8% +$2.01M 0.02% 283
2023
Q3 		$26.8M Sell
410,090
-110,606
-21% -$6.96M 0.02% 273
2023
Q2 		$30.3M Sell
520,696
-67,573
-11% -$4.26M 0.02% 263
2023
Q1 		$36.3M Buy
588,269
+79,279
+16% +$4.76M 0.03% 231
2022
Q4 		$32.4M Buy
508,990
+102,953
+25% +$7.47M 0.03% 258
2022
Q3 		$29.5M Sell
406,037
-107,321
-21% -$7.99M 0.03% 260
2022
Q2 		$34.9M Sell
513,358
-290,589
-36% -$20.9M 0.03% 224
2022
Q1 		$72.9M Buy
803,947
+48,470
+6% +$3.97M 0.05% 154
2021
Q4 		$69M Buy
755,477
+480,150
+174% +$41.1M 0.04% 173
2021
Q3 		$22.3M Buy
+275,327
New +$23.1M 0.01% 347
2020
Q3 		– Sell
-44,733
Closed -$2.17M – 698
2020
Q2 		$2.17M Buy
+44,733
New +$2.14M ﹤0.01% 465

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Jennison Associates's NARI Position: Q1 2025 in Review

Jennison Associates sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 1,763,258 shares — an estimated $90M sold.

Jennison Associates first reported a position in NARI in Q2 2020 and held it in 15 quarters. The position peaked at $90M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Jennison Associates reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Jennison Associates sold 1,763,258 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $90M.
  • Jennison Associates first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Jennison Associates's Inari Medical, Inc. Common Stock position peaked at $90M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Jennison Associates's 13F filing for Q1 2025, filed 5 May 2025.